» Articles » PMID: 26552807

Improving Rates of Maternal Immunization: Challenges and Opportunities

Overview
Date 2015 Nov 11
PMID 26552807
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: An increasing number of vaccines are recommended or are being developed for use during pregnancy to protect women, fetuses, and/or newborns. For vaccines that are already recommended, vaccine uptake is variable and well below desired target. We reviewed the literature related to factors that affect a healthcare provider's recommendation and a woman's willingness to be vaccinated during pregnancy.

Design: A scoping review of published literature from 2005 to 2015 was undertaken and all relevant articles were abstracted, summarized, and organized thematically.

Results: Barriers and facilitators were identified that either decreased or increased the likelihood of a healthcare provider offering and a pregnant woman accepting vaccination during pregnancy. Concern about the safety of vaccines given during pregnancy was the most often cited barrier among both the public and healthcare providers. Other barriers included doubt about the effectiveness of the vaccine, lack of knowledge about the burden of disease, and not feeling oneself to be at risk of the infection. Major facilitators for maternal immunization included specific safety information about the vaccine in pregnant women, strong national recommendations, and healthcare providers who both recommended and provided the vaccine to their patients. Systems barriers such as inadequate facilities and staffing, vaccine purchase and storage, and reimbursement for vaccination were also cited. Evidence-based interventions were few, and included text messaging reminders, chart reminders, and standing orders.

Conclusions: In order to have an effective vaccination program, improvements in the uptake of recommended vaccines during pregnancy are needed. A maternal immunization platform is required that normalizes vaccination practice among obstetrical care providers and is supported by basic and continuing education, communication strategy, and a broad range of research.

Citing Articles

Insights into maternal pertussis vaccination counselling: a qualitative study on perspectives and experiences among midwives and gynaecologists in the Netherlands.

Widdershoven V, van Eerd E, Pfeyffer M, Vanderhoven L, Verhaegh-Haasnoot A, Reijs R BMC Infect Dis. 2024; 24(1):903.

PMID: 39223488 PMC: 11367930. DOI: 10.1186/s12879-024-09681-7.


"I try to take all the time needed, even if i do not have it!": Knowledge, attitudes, practices of perinatal care providers in canada about vaccination.

Pringle W, Greyson D, Graham J, Dube E, Mitchell H, Russell M Vaccine X. 2024; 18:100490.

PMID: 38699156 PMC: 11063514. DOI: 10.1016/j.jvacx.2024.100490.


Maternal awareness, acceptability and willingness towards respiratory syncytial virus (RSV) vaccination during pregnancy in Ireland.

McCormack S, Thompson C, Nolan M, Imcha M, Dee A, Saunders J Immun Inflamm Dis. 2024; 12(4):e1257.

PMID: 38661110 PMC: 11044221. DOI: 10.1002/iid3.1257.


"I was having an internal conflict with myself." COVID-19 vaccination decision-making processes among pregnant women.

Narasimhan S, Perry T, Johnson L Womens Health (Lond). 2023; 19:17455057231218211.

PMID: 38130103 DOI: 10.1177/17455057231218211.


Sources of COVID-19 Vaccine Promotion for Pregnant and Lactating Women in Bangladesh.

Fesshaye B, Wade S, Lee C, Singh P, Zavala E, Ali H Vaccines (Basel). 2023; 11(8).

PMID: 37631955 PMC: 10459640. DOI: 10.3390/vaccines11081387.


References
1.
McCarthy E, Pollock W, Nolan T, Hay S, McDonald S . Improving influenza vaccination coverage in pregnancy in Melbourne 2010-2011. Aust N Z J Obstet Gynaecol. 2012; 52(4):334-41. DOI: 10.1111/j.1479-828X.2012.01428.x. View

2.
McCarthy E, Pollock W, Tapper L, Sommerville M, McDonald S . Increasing uptake of influenza vaccine by pregnant women post H1N1 pandemic: a longitudinal study in Melbourne, Australia, 2010 to 2014. BMC Pregnancy Childbirth. 2015; 15:53. PMC: 4352234. DOI: 10.1186/s12884-015-0486-3. View

3.
Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K . Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014; 384(9953):1521-8. DOI: 10.1016/S0140-6736(14)60686-3. View

4.
. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep. 2013; 62(7):131-5. PMC: 4604886. View

5.
Trick W, Linn E, Jones Z, Caquelin C, Kee R, Morita J . Using computer decision support to increase maternal postpartum tetanus, diphtheria, and acellular pertussis vaccination. Obstet Gynecol. 2010; 116(1):51-57. DOI: 10.1097/AOG.0b013e3181e40a9f. View